Europe — EMA

Orlistat Stada

Orlistat, the active ingredient in Orlistat Stada, is a lipase inhibitor presented as a unknown/unknown for oral use. It treats obesity by reducing dietary fat absorption in adults.

Orlistat

Request sourcing

Pack/s

What is Orlistat?

Orlistat, the active ingredient in Orlistat Stada, is a lipase inhibitor presented as a unknown/unknown for oral use. It treats obesity by reducing dietary fat absorption in adults. GNH USA supplies Orlistat Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orlistat Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Orlistat used for?

Orlistat is a weight‑management drug that acts on gastrointestinal fat digestion.

- Obesity: Helps ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - ... … ... ... bullet ... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →